|
![]() |
gadoteridolThis page contains recent news articles, when available, and an overview of gadoteridol but does not offer medical advice. You should contact your physician with regard to any health issues or concerns....(gadobenate dimeglumine); or Prohance (gadoteridol), you are strongly encouraged to contact an attorney now to discuss the pending gadolinium lawsuit. US Recall News (press release), NSF NFD Gadolinium Lawyers offer Nationwide Assistance to Patients - Jan 16, 2008 Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); MultiHance;(gadobenate dimeglumine);and Prohance (gadoteridol). Press Media Wire (Press Release), Boxed Warning Added for Gadolinium-Based Contrast Agents - Oct 1, 2007 ...by gadopentetate dimeglumine and gadoversetamide; NSF has also been reported following sequential use of gadodiamide with dimeglumine or gadoteridol. Medscape (subscription) Bracco Diagnostics Inc. and - Oct 5, 2007 This agreement includes MultiHance ® (gadobenate dimeglumine) injection, 529 mg/mL and ProHance ® (gadoteridol) injection 279.3 mg/mL. Ad-Hoc-News (Pressemitteilung), Contrast Agent Linked to Fibrosing Disorder in Dialysis Patients - Oct 1, 2007 529 mg/mL, Omniscan (gadodiamide) injection, OptiMARK (gadoversetamide) injection, and ProHance (gadoteridol) injection, 279.3 mg/mL. MedPage Today, TODAY ON PHARMALIVE.COM - 03 Jul 2007 PharmaLive.com (press release),Magnevist (gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); MultiHance;(gadobenate dimeglumine); and Prohance (gadoteridol). MRI for Profit Scheme May Turn Deadly - Jun 10, 2007 Lawyers and Settlements,MultiHance; (gadobenate dimeglumine); and Prohance (gadoteridol). Bayer Schering Pharma manufactures Magnevist; GE Healthcare is the maker of Omniscan; FDA Requests Boxed Warning for Contrast Agents Used to Improve MRI - 25 May 2007 NewsBlaze,...(gadopentetate dimeglumine), Ominiscan (gadodiamide); OptiMARK (gadoversetamide); MultiHance;(gadobenate dimeglumine);and Prohance (gadoteridol). FDA Orders Black Box Warning for Gadolinium-Based Contrast Agents - May 23, 2007 MedPage Today,...systemic fibrosis also has developed after the sequential administration of gadodiamide, and gadobenate dimeglumine and gadomiamide and gadoteridol. MRI Contrast Agents May Pose Risk for Patients With Kidney Disease - Jan 16, 2007 Journal of American Medical Association (subscription),So far, no cases have been reported with patients taking gadoteridol (ProHance) or gadobenate dimeglumine (MultiHance). Kanal does not know if absence of : |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines mongabay.com
COPYRIGHT 2007 MONGABAY.COM |